Multimodal Deep Learning Network Achieves 96% Accuracy in Brain Tumor Classification
Researchers developed a two-branch neural network that combines MRI scans with 91 radiomic features to classify brain tumors, achieving 96.13% accuracy with a gated fusion strategy. The model addresses a gap in existing deep learning approaches, which typically rely on imaging data alone and do not replicate the multimodal reasoning clinicians use in diagnosis. The work suggests that integrating quantitative radiomic descriptors with image data meaningfully improves automated tumor classification performance.
A preprint posted to arXiv presents a multimodal neural network designed to classify brain tumors into four categories—glioma, meningioma, pituitary tumor, and no tumor—by combining raw MRI scans with 91 extracted radiomic features covering intensity, texture, shape, and boundary descriptors. The architecture uses a pre-trained CNN backbone to encode the imaging stream and a dedicated multilayer perceptron (MLP) to encode the radiomic stream, with the two streams merged via one of three fusion strategies: concatenation, gated attention, or bidirectional cross-modal attention. Across nine experimental runs on a balanced dataset of 7,200 images, all multimodal configurations outperformed unimodal (image-only) baselines, with gated fusion yielding the highest accuracy of 96.13%. The authors frame the approach as a computational analog to clinical practice, where physicians integrate imaging findings with patient history and symptom data rather than relying on scans alone. The study was submitted to arXiv in June 2026 and has not yet undergone formal peer review.
What's missing
As a preprint, the study has not been peer-reviewed. Key limitations not addressed in the abstract include: the model's performance on external or real-world clinical datasets (generalizability); whether radiomic features were extracted from the same MRI sequences used for image classification; and how the model handles class imbalance or rare tumor subtypes beyond the four categories tested. The clinical deployment pathway and comparison against radiologist-level performance are also not discussed.
What different sources said
- arXiv cs.LGCenter
Multimodal Brain Tumour Classification Using Feature Fusion
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.